United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 2.5 mg - neoplastic diseases methotrexate is indicated in the treatment of gestational choriocarcinoma, chorio-adenoma destruens and hydatidiform mole. methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. psoriasis methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation . it is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affec

United States - English - NLM (National Library of Medicine)

rebel distributors corp - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 2.5 mg - neoplastic diseases methotrexate is indicated in the treatment of gestational choriocarcinoma, chorio-adenoma destruens and hydatidiform mole. methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. psoriasis methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation . it is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affec

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 2.5 mg - methotrexate tablets are indicated in the treatment of gestational choriocarcinoma, chorio-adenoma destruens and hydatidiform mole. methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. methotrexate tablets are indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation . it is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affec

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - methotrexate, quantity: 1000 mg - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - antineoplastic chemotherapy:,methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer and the palliation of acute and subacute lymphocytic leukaemia (greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias). methotrexate is now most commonly used for the maintenance of drug induced remissions.,high dose therapy:,in high dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic sarcoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy.,psoriasis chemotherapy (see warnings box and section 4.4 special warnings and precautions for use):,methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, m

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - methotrexate, quantity: 500 mg - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - antineoplastic chemotherapy:,methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer and the palliation of acute and subacute lymphocytic leukaemia (greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias). methotrexate is now most commonly used for the maintenance of drug induced remissions.,high dose therapy:,in high dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic sarcoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy.,psoriasis chemotherapy (see warnings box and section 4.4 special warnings and precautions for use):,methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, m

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - methotrexate (unii: yl5fz2y5u1) (methotrexate - unii:yl5fz2y5u1) - methotrexate 2.5 mg - methotrexate tablets are indicated for the: -   treatment of adults and pediatric patients with acute lymphoblastic leukemia (all) as part of a combination chemotherapy maintenance regimen -   treatment of adults with mycosis fungoides (cutaneous t-cell lymphoma) as a single agent or as part of a combination chemotherapy regimen. -   treatment of adults with relapsed or refractory non-hodgkin lymphomas as part of a metronomic combination chemotherapy regimen methotrexate tablets are indicated for the treatment of adults with rheumatoid arthritis. methotrexate tablets are indicated for the treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pjia). methotrexate tablets are indicated for the treatment of adults with severe psoriasis. methotrexate tablets are contraindicated in: - pregnant women receiving methotrexate tablets for treatment of non-neoplastic diseases [see warnings and precautions (5.1), and use in specific populations (8.1, 8.3)] . - patients with a

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 2.5 mg - methotrexate tablets is indicated for the: - treatment of adults and pediatric patients with acute lymphoblastic leukemia (all) as part of a combination chemotherapy maintenance regimen - treatment of adults with mycosis fungoides (cutaneous t-cell lymphoma) as a single agent or as part of a combination chemotherapy regimen. - treatment of adults with relapsed or refractory non-hodgkin lymphomas as part of a metronomic combination chemotherapy regimen methotrexate tablets is indicated for the treatment of adults with rheumatoid arthritis. methotrexate tablets is indicated for the treatment of adults with severe psoriasis. methotrexate tablets is contraindicated in: - pregnant women receiving methotrexate tablets for treatment of non-neoplastic diseases [see warnings and precautions (5.1), and use in specific populations (8.1, 8.3)] . - patients with a history of a severe hypersensitivity reactions, including anaphylaxis, to methotrexate. [see warnings and precautions (5.2)] . risk summary methotrexate tab

United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - methotrexate (unii: yl5fz2y5u1) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml - methotrexate injection is indicated for the treatment of adult and pediatric patients with acute lymphoblastic leukemia (all) as part of a combination chemotherapy regimen. methotrexate injection is indicated for the prophylaxis and treatment of meningeal leukemia in adult and pediatric patients. methotrexate injection is indicated for the treatment of adults and pediatric patients with non-hodgkin lymphoma. methotrexate injection is indicated for the treatment of adults and pediatric patients with osteosarcoma as part of a combination chemotherapy regimen. methotrexate injection is indicated for the treatment of adults with breast cancer as part of a combination chemotherapy regimen. methotrexate injection is indicated for the treatment of adults with squamous cell carcinoma of the head and neck as a single-agent. methotrexate injection is indicated for the treatment of adults with gestational trophoblastic neoplasia (gtn) as part of a combination chemotherapy regimen. methotrexate injection is indicated for

United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml - methotrexate injection is indicated for the treatment of adult and pediatric patients with acute lymphoblastic leukemia (all) as part of a combination chemotherapy regimen. methotrexate injection is indicated for the prophylaxis and treatment of meningeal leukemia in adult and pediatric patients. methotrexate injection is indicated for the treatment of adults and pediatric patients with non-hodgkin lymphoma. methotrexate injection is indicated for the treatment of adults and pediatric patients with osteosarcoma as part of a combination chemotherapy regimen. methotrexate injection is indicated for the treatment of adults with breast cancer as part of a combination chemotherapy regimen. methotrexate injection is indicated for the treatment of adults with squamous cell carcinoma of the head and neck as a single-agent. methotrexate injection is indicated for the treatment of adults with gestational trophoblastic neoplasia (gtn) as part of a combination chemotherapy regimen. methotrexate injection is indicated for